The development of stereotactic body radiotherapy in the past decade: a global perspective

Simon S Lo; Ben J Slotman; Michael Lock; Yasushi Nagata; Matthias Guckenberger; Shankar Siva; Matthew Foote; Daniel Tan; Bin S Teh; Nina A Mayr; Eric L Chang; Robert D Timmerman; Arjun Sahgal

doi:10.2217/fon.15.220

The development of stereotactic body radiotherapy in the past decade: a global perspective

Future Oncol. 2015 Oct;11(19):2721-2733. doi: 10.2217/fon.15.220. Epub 2015 Sep 4.

Authors

Simon S Lo¹, Ben J Slotman², Michael Lock³, Yasushi Nagata⁴, Matthias Guckenberger⁵, Shankar Siva⁶, Matthew Foote⁷, Daniel Tan⁸, Bin S Teh⁹, Nina A Mayr¹⁰, Eric L Chang¹¹, Robert D Timmerman¹², Arjun Sahgal¹³

Affiliations

¹ Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, OH, USA.
² Department of Radiation Oncology, VU University Medical Center, Amsterdam, The Netherlands.
³ Department of Radiation Oncology, London Regional Cancer Program, University of Western Ontario, London, ON, Canada.
⁴ Department of Radiation Oncology, Hiroshima University, Hiroshima, Japan.
⁵ Department of Radiation Oncology, University of Zurich, Zurich, Switzerland.
⁶ Division of Radiation Oncology, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.
⁷ Department of Radiation Oncology, Princess Alexandra Hospital, School of Medicine, University of Queensland, Queensland, Australia.
⁸ Asian American Radiation Oncology, Singapore.
⁹ Department of Radiation Oncology, Houston Methodist Hospital, Weill Cornell Medical College, Houston, TX, USA.
¹⁰ Department of Radiation Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
¹¹ Department of Radiation Oncology, Keck School of Medicine & Norris Cancer Center at the University of Southern California, Los Angeles, CA, USA.
¹² Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
¹³ Department of Radiation Oncology, Sunnybrook Health Sciences Center, University of Toronto, Toronto, ON, Canada.

PMID: 26338676
DOI: 10.2217/fon.15.220

Abstract

In the past 10 years, there has been an exponential increase in the incorporation of stereotactic body radiotherapy, also known as stereotactic ablative radiotherapy, into the armamentarium against various types of cancer in different settings worldwide. In this article in the 10th year anniversary issue of Future Oncology, representatives from the USA, Canada, Japan, Germany, The Netherlands, Australia and Singapore will provide individual perspectives of the development of stereotactic body radiotherapy in their respective countries.

Keywords: global; stereotactic body radiotherapy.